Highline Wealth Partners’s Takeda Pharmaceutical TAK Stock Holding History
Bought
Maintained
Sold
Other funds holding TAK
Highline Wealth Partners's TAK Position: Q3 2026 in Review
Highline Wealth Partners increased its Takeda Pharmaceutical (TAK) stake by 72% in Q3 2026, buying an estimated $3.79K and bringing the position to 510 shares worth $9.28K. The position accounts for ﹤0.01% of the portfolio, ranked #725.
Highline Wealth Partners first reported a position in TAK in Q1 2025 and has held it in 7 quarters since. 366 funds tracked by Wall St. Rank hold TAK as of Q3 2026.
- Highline Wealth Partners held 510 shares of Takeda Pharmaceutical worth $9.28K as of Q3 2026.
- Highline Wealth Partners bought 214 Takeda Pharmaceutical shares in Q3 2026, an estimated $3.79K.
- Takeda Pharmaceutical made up ﹤0.01% of Highline Wealth Partners's portfolio in Q3 2026, its #725 holding.
- Highline Wealth Partners first reported a position in Takeda Pharmaceutical in Q1 2025 and has held it in 7 quarters since.
- 366 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q3 2026.
Based on Highline Wealth Partners's 13F filing for Q3 2026, filed 19 Oct 2026.